HWM
HighMark Wealth Management Portfolio holdings
AUM
$205M
This Quarter Return
-4.21%
1 Year Return
+18.44%
3 Year Return
+65.97%
5 Year Return
+111.28%
10 Year Return
–
AUM
$121M
AUM Growth
+$121M
(-9.4%)
Cap. Flow
-$6.61M
Cap. Flow
% of AUM
-5.48%
Top 10 Holdings %
Top 10 Hldgs %
74.38%
Holding
590
New
27
Increased
162
Reduced
82
Closed
24
Top Buys
| 1 |
Protolabs
PRLB
|
$127K |
| 2 |
AtriCure
ATRC
|
$78.8K |
| 3 |
SCTL
Societal CDMO, Inc. Common Stock
SCTL
|
$73.2K |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
$64K |
| 5 |
Alibaba
BABA
|
$60.7K |
Top Sells
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$2.16M |
| 2 |
Krystal Biotech
KRYS
|
$2.02M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
$611K |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
$577K |
| 5 |
Halozyme
HALO
|
$401K |
Sector Composition
| 1 | Healthcare | 7.91% |
| 2 | Financials | 4.48% |
| 3 | Technology | 3.39% |
| 4 | Consumer Discretionary | 2.75% |
| 5 | Industrials | 1.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Travelers Companies
TRV
$62.3B
| $477K | 0.4% |
2,920
+18
| +0.6% | +$2.94K |
|
27
Aurinia Pharmaceuticals
AUPH
$1.58B
| $466K | 0.39% |
59,999
-2,500
| -4% | -$19.4K |
|
28
NVIDIA
NVDA
$4.15T
| $428K | 0.35% |
983
+3
| +0.3% | +$1.31K |
|
29
Abbott
ABT
$230B
| $408K | 0.34% |
4,210
-47
| -1% | -$4.55K |
|
30
Vanguard Total Stock Market ETF
VTI
$524B
| $401K | 0.33% |
1,960
+248
| +14% | +$50.8K |
|
31
Xcel Energy
XEL
$42.8B
| $393K | 0.33% |
6,873
-267
| -4% | -$15.3K |
|
32
Exxon Mobil
XOM
$477B
| $356K | 0.3% |
3,029
+21
| +0.7% | +$2.47K |
|
33
HSBC
HSBC
$224B
| $355K | 0.29% |
9,008
| – | – |
|
34
Prothena Corp
PRTA
$452M
| $355K | 0.29% |
7,352
| – | – |
|
35
iShares S&P 100 ETF
OEF
$22.1B
| $346K | 0.29% |
1,724
| – | – |
|
36
Ecolab
ECL
$77.5B
| $342K | 0.28% |
2,017
+6
| +0.3% | +$1.02K |
|
37
KORU Medical Systems
KRMD
$187M
| $327K | 0.27% |
120,935
| – | – |
|
38
Vanguard Large-Cap ETF
VV
$44.3B
| $326K | 0.27% |
1,668
| – | – |
|
39
QuidelOrtho
QDEL
$1.87B
| $313K | 0.26% |
4,290
| – | – |
|
40
DexCom
DXCM
$30.9B
| $299K | 0.25% |
3,209
+230
| +8% | +$21.5K |
|
|
41
Protolabs
PRLB
$1.17B
| $263K | 0.22% |
9,945
+4,800
| +93% | +$127K |
|
42
Costco
COST
$421B
| $230K | 0.19% |
407
| – | – |
|
|
SCTL
43
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $227K | 0.19% |
484,985
+155,997
| +47% | +$73.2K |
|
44
iShares MSCI EAFE ETF
EFA
$65.4B
| $227K | 0.19% |
3,297
+6
| +0.2% | +$414 |
|
45
Automatic Data Processing
ADP
$121B
| $191K | 0.16% |
792
| – | – |
|
46
iShares Russell Mid-Cap ETF
IWR
$44B
| $189K | 0.16% |
2,722
| – | – |
|
47
Johnson & Johnson
JNJ
$429B
| $187K | 0.16% |
1,201
+9
| +0.8% | +$1.4K |
|
48
iShares Core MSCI EAFE ETF
IEFA
$149B
| $185K | 0.15% |
2,878
+234
| +9% | +$15.1K |
|
49
PepsiCo
PEP
$203B
| $171K | 0.14% |
1,007
-78
| -7% | -$13.2K |
|
50
SPDR S&P Biotech ETF
XBI
$5.29B
| $164K | 0.14% |
2,245
| – | – |
|